- Home
- INO vs PAI Comparison
INO vs PAI Comparison
Compare INO & PAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | PAI |
|---|---|---|
| Founded | 1979 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 118.3M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | PAI |
|---|---|---|
| Price | $1.55 | $12.09 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 647.3K | 13.5K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.78% |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,220,086.00 | N/A |
| Revenue This Year | $24,407.60 | N/A |
| Revenue Next Year | $331.40 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.30 | $11.41 |
| 52 Week High | $2.86 | $13.22 |
Technical Indicators
Market Signals| Indicator | INO | PAI |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 37.59 |
| Support Level | $1.48 | N/A |
| Resistance Level | $1.60 | $12.60 |
| Average True Range (ATR) | 0.07 | 0.13 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 6.25 | 46.48 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About PAI Western Asset Investment Grade Income Fund Inc.
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.